Colin Clancy

Vice President, Investor Relations and Corporate Communications at InMed Pharmaceuticals - Vancouver, BC, CA

Colin Clancy's Colleagues at InMed Pharmaceuticals
Eric Hsu

VP of Preclinical R&D

Contact Eric Hsu

Karen Long

Sr. Director, Drug Development

Contact Karen Long

Eric Adams

CEO + President, Director

Contact Eric Adams

Michael W.

Vice President, Chemistry Manufacturing and Control (CMC)

Contact Michael W.

View All Colin Clancy's Colleagues
Colin Clancy's Contact Details
HQ
604-669-7207
Location
Vancouver,Distrito Metropolitano de Quito,Pichincha,170206,Ecuador
Company
InMed Pharmaceuticals
Colin Clancy's Company Details
InMed Pharmaceuticals logo, InMed Pharmaceuticals contact details

InMed Pharmaceuticals

Vancouver, BC, CA • 20 - 49 Employees
BioTech/Drugs

InMed Pharmaceuticals is a global leader in the development, manufacturing and commercialization of rare cannabinoids. Together with our subsidiary, BayMedica, we have unparalleled cannabinoid manufacturing capabilities to serve a spectrum of consumer markets, including pharmaceutical and health and wellness. InMed is a clinical-stage company developing a pipeline of rare cannabinoid therapeutics and dedicated to delivering new treatment alternatives to patients that may benefit from cannabinoid-based pharmaceutical drugs. For more information, visit www.inmedpharma.com. Nasdaq: INM

N/A
Details about InMed Pharmaceuticals
Frequently Asked Questions about Colin Clancy
Colin Clancy currently works for InMed Pharmaceuticals.
Colin Clancy's role at InMed Pharmaceuticals is Vice President, Investor Relations and Corporate Communications.
Colin Clancy's email address is ***@inmedpharma.com. To view Colin Clancy's full email address, please signup to ConnectPlex.
Colin Clancy works in the Research industry.
Colin Clancy's colleagues at InMed Pharmaceuticals are Eric Hsu, Shane Johnson, Karen Long, Eric Adams, Michael W., Sarah Li and others.
Colin Clancy's phone number is 604-669-7207
See more information about Colin Clancy